PREMIER BIOMEDICAL COM USD0.001 (BIEI)

0.01
0.00 7.08
OTC
Prev Close 0.01
Open 0.01
Day Low/High 0.01 / 0.01
52 Wk Low/High 0.00 / 0.09
Volume 3.17M
Exchange OTC
Shares Outstanding 125.72B
Market Cap 1.51M
Div & Yield N.A. (N.A)

Premier Biomedical, Inc. Cancer Immunotherapy Research Highlights To Be Presented At AACR Conference

Premier Biomedical, Inc. ( OTCQB: BIEI) announced additional details regarding the presentation of the stunning results of their cancer immunotherapy research, along with additional research results by their UTEP...

Premier Biomedical, Inc. Engages Agent To Identify Suitable Joint Venture Partners In China And Europe

Premier Biomedical, Inc. ( OTCQB: BIEI) announced that they have engaged the services of an agent affiliated with the Chinese pharmaceutical industry to seek out suitable joint venture partners in China and Europe.

Premier Biomedical, Inc. Engages Agent In India To Identify Suitable Joint Venture Partners In Asia

Premier Biomedical, Inc. ( OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, announced that they have engaged...

Zika Virus Suspected To Be Transmitted Sexually; Premier Biomedical Inc. Increases Focus; Optimistic Their Patented Extracorporeal Methodology Could Be Most Effective Treatment

Premier Biomedical, Inc. ( OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, noted that the CDC reported...

Premier Biomedical Inc. Optimistic Their Patented Methodology Will Be Effective In Treating Dengue And Zika Virus

Premier Biomedical, Inc. ( OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, announced today that they believe...

Premier Biomedical, Inc. Releases Video "A Scientific Roadmap To Cure Cancer"

Premier Biomedical, Inc.( OTCQB: "BIEI") a biotech research company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for...

Premier Biomedical Announces Intended $6 Million Investment By Brazilian Joint Venture Partner, Auramedi, To Manufacture, Market And Distribute Premier's New Technology Products

Premier Biomedical, Inc.( OTCQB:"BIEI") a biotech research company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast...

Premier Biomedical Files Provisional Patent Application On Second Drug To Treat Fibromyalgia, Neuropathic Pain, MS Symptoms, And Alcohol And Chemical Addiction

Premier Biomedical, Inc.( OTCQB:"BIEI") a biotech research company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast...

Premier Biomedical CEO In Radio Interview Discusses Core Technology, Immunotherapy, Neuropathy Medication And Planned Series Of Joint Ventures In Brazil, Asia And Europe For 2016

Premier Biomedical, Inc. ( OTCQB:BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for...

Broad-Based Patent Involving Innovative Extracorporeal Treatment Therapy Issued - Premier Biomedical Believes This Could Lead To Cancer Cure

Premier Biomedical, Inc. ( OTCQB:BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for...

Premier Biomedical Announces $1.6mil Financing - Consolidates Funding Needs Through 2016

Premier Biomedical, Inc. ( OTCQB: "BIEI") a biotech research company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for...

Premier Biomedical Recognized For Huge Growth Potential

Premier Biomedical, Inc.( OTCQB: "BIEI") a biotech research company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for...

Scientist Working With Premier Biomedical Invited To Present Possible Breakthrough Findings On Chemotherapy Treatment At San Antonio Breast Cancer Symposium Educational Session

Premier Biomedical, Inc. ( OTCQB:BIEI) a biotech research company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast...

Premier Biomedical Receives Notice Of Allowance On Broad Base Patent Involving Innovative Extracorporeal Treatment Therapy - Premier Believes This May Lead To Cancer Cure

Premier Biomedical, Inc. ( OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for...

Premier Biomedical And Auramedi FarmacĂȘutica Agree To Explore Forming Joint Venture In Brazil

Premier Biomedical, Inc. ( OTCQB:BIEI), a biotech research public company, and Auramedi FarmacĂȘutica Ltda (a Brazilian pharmaceutical company) announced the signing of a non-binding Letter of Intent (LOI) to enter into...

Premier Biomedical, Inc. Accomplishments And Recent News

Premier Biomedical, Inc. (PBI) is a publicly traded (OTCQB: BIEI) research-based company that intends to discover and develop medical treatments targeting the treatment of heretofore incurable and/or hard-to-cure diseases.

Premier Biomedical Announces The Addition Of Drs. Carl And Kathryn Meyer To Scientific Advisory Board

Premier Biomedical, Inc. (OTCQB: " BIEI") announced the addition of Dr.

Premier Biomedical Announces The Addition Of Dr. James Frincke To Scientific Advisory Board

Premier Biomedical, Inc. (OTCQB: " BIEI") announced the addition of Dr.

Premier Biomedical, Inc. Signs Deal With Consultant Team In Brazil To Arrange Possible JV Partnerships For Growth

Premier Biomedical, Inc. ( OTCQB: BIEI) announced that they have agreed to terms whereby FBROCCO Assessoria Empresarial Ltda, will act in Premier's interests in locating and securing financing and possible joint venture...

Premier Biomedical Announces The Addition Of Dr. Ryan C. Fields To Scientific Advisory Board

Premier Biomedical, Inc. (OTCBB: " BIEI") announced the addition of Dr.

Premier Biomedical Files Initial FDA Submission For Fibromyalgia Treatment

Premier Biomedical, Inc. (OTCBB: BIEI) announced that they intend to nationally sell an exclusively licensed and patented drug treatment for fibromyalgia.

OxBridge Research Publishes A Comprehensive Research Report On Premier Biomedical

Premier Biomedical, Inc. (OTCBB: " BIEI") a biopharmaceutical company focused on developing and commercializing innovative treatment therapies for cancer, traumatic brain injury, Alzheimer's disease, and other...

Premier Biomedical Announces The Addition Of Dr. Patricio Reyes To Scientific Advisory Board

Premier Biomedical, Inc. (OTCBB: BIEI) announced the addition of Dr.

Premier Biomedical Announces The Addition Of K. Adam Dubov, Esq. To Scientific Advisory Board

Premier Biomedical, Inc. (OTCBB: " BIEI") announced the addition of K.

Premier Biomedical, Inc. (BIEI) Announces Important Patent Award For A Potential Multi-Billion Dollar Drug For The Treatment Of Fibromyalgia And Neuralgia

Premier Biomedical, Inc. (OTCBB: “BIEI”) a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation therapies for breast cancer, Alzheimer’s disease, multiple...

Premier Biomedical Releases Anti-CTLA4 Market Study

Premier Biomedical Inc. (OTCBB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune system manipulation therapies for breast cancer, as well as potential novel therapies for...